实用临床医药杂志2012，Vol.16Issue(21)：94-96,3.
奥扎格雷钠联合低分子肝素治疗进展性脑梗死疗效观察
A clinical study of sodium ozagrel injection combined with low molecular weight heparin sodium on progressive cerebral infarction
摘要
Abstract
Objective To observe the therapeutic effect of sodium ozagrel injection combined with low molecular weight heparin sodium in the treatment of progressive cerebral infarction. Methods Eighty patients were randomly divided into treatment group and control group, which were administered sodium ozagrel + low molecular weight heparin sodium and low molecular weight heparin sodium, respectively. The degree of neurological deficit were assessed according to the U. S. National Institutes of Health Stroke Scale (NIHSS) score and activities of daily living (ADL) in two groups before treatment, and 14 days after treatment. Results The excellence rates in the treatment and control group were 69. 77% and 47. 62% , respectively 14 days after treatment. The rate of improvement in the combined group was better than that of the control group( P< 0. 05). No complications of gastrointestinal bleeding, intracranial hemorrhage were identifed in both groups. Conclusion Sodium ozagrel injection combined with low molecular weight heparin sodium is safe and reliable in treating progressive cerebral infarction, which is worthy of clinical use.关键词
奥扎格雷钠/低分子肝素钠/进展期脑梗死/疗效Key words
ozagrel/low molecular weight heparin sodium/progressive cerebral infarction/curative effect分类
医药卫生引用本文复制引用
卢兰香..奥扎格雷钠联合低分子肝素治疗进展性脑梗死疗效观察[J].实用临床医药杂志,2012,16(21):94-96,3.基金项目
中国高校医学期刊临床专项资金(11220218) （11220218）
